PROX1 and gastric cancer: Upregulated PROX1 expression was significantly correlated with tumor differentiation, tumor size, metastasis, depth of invasion, and cancer stages in several human tumors, which include gastric cancer [11], hepatocellular carcinoma [27], esophageal squamous cell carcinoma [28], renal cell carcinoma [29].